Summit Therapeutics (SMMT) Revenue (2019 - 2022)
Summit Therapeutics (SMMT) posted Revenue of $220000.0 for Q3 2022, down 6.38% on a QoQ basis from $235000.0 in Q2 2022, and down 83.19% year-over-year from $1.3 million in Q3 2021.
Summit Therapeutics (SMMT) Revenue (2019 - 2022) Analysis & Trends
Summit Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $220000.0 for Q3 2022.
- Quarterly Revenue fell 83.19% year-over-year to $220000.0 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $220000.0 (down 89.24% YoY) and the FY2022 annual result came in at $705000.0, down 61.03% from the prior year.
- Revenue was $220000.0 for Q3 2022 at Summit Therapeutics, down from $235000.0 in the prior quarter.
- Across five years, Revenue topped out at $1.3 million in Q3 2021 and bottomed at -$52000.0 in Q4 2019.
- A 4-year average of $266923.1 and a median of $192000.0 in 2021 frame the typical range for Revenue.
- Annual changes were most pronounced in 2021 — Revenue soared 623.2% — and 2022, when it tumbled 83.19%.
- Summit Therapeutics' Revenue stood at -$52000.0 in 2019, then surged by 455.77% to $185000.0 in 2020, then surged by 35.68% to $251000.0 in 2021, then slipped by 12.35% to $220000.0 in 2022.
- Business Quant data shows SMMT's Revenue at $220000.0 in Q3 2022, $235000.0 in Q2 2022, and $250000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Summit Therapeutics | 10.60 Bn | 10.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 220,000.00 |
| Jun 30, 2022 | 235,000.00 |
| Mar 31, 2022 | 250,000.00 |
| Dec 31, 2021 | 251,000.00 |
| Sep 30, 2021 | 1.31 Mn |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | 192,000.00 |
| Dec 31, 2020 | 185,000.00 |
| Sep 30, 2020 | 181,000.00 |
| Jun 30, 2020 | 170,000.00 |
| Mar 31, 2020 | 324,000.00 |
| Dec 31, 2019 | -52,000.00 |
| Sep 30, 2019 | 148,000.00 |